In a bold move aimed at combating the illegal sale of prescription medications, the Ministry of Health has unveiled a new online platform designed for the declaration of batch numbers associated with all health products that are either imported, exported, or manufactured locally. This significant announcement was made by Health Cabinet Secretary Aden Duale on December 23, where he outlined new strategies to tighten regulations around prescription-only drugs.
Set to launch on January 1, 2026, this online system will mandate batch number declarations, making compliance not just a recommendation but a requirement. The central goal of this initiative is to enhance the government’s oversight on how prescription medicines are distributed and sold across the country.
Additionally, Duale announced that the Ministry has successfully developed a Track and Authentication Standard for Health Products and Technologies. This innovative technology is intended to improve traceability, accountability, and visibility throughout the pharmaceutical supply chain, which is crucial for ensuring public safety.
During a recent press briefing held outside Kenyatta National Hospital in Nairobi, Health CS Aden Duale emphasized that the Ministry is undertaking comprehensive inspections of all licensed wholesalers in the Nairobi Region as part of the preparations for the upcoming 2026 licensing cycle. He pointed out that any practitioners found in violation of these new standards would be referred to the Board’s Ethics and Disciplinary Committee (EDC) for appropriate disciplinary measures.
Sanctions from the EDC can range from suspending to outright revocation of medical licenses, which underscores the seriousness of non-compliance. Notably, over ten practitioners have already faced the EDC due to such violations.
The newly appointed EDC board members, who commenced their roles on November 7, are expected to be fully operational by January 2026. Their responsibilities will include addressing unresolved cases and processing referrals of additional practitioners who fail to adhere to regulations.
In his statement, Duale also shared that the Ministry is nearing completion of the scheduling process for various medicines, which will soon be available to the public in Kenya. This move is part of a broader strategy to enhance regulatory clarity, provide support for practitioners in meeting compliance standards, and bolster enforcement actions against those who violate the rules.
Moreover, the Ministry has approved the hiring of more regulatory staff, a decision anticipated to substantially improve inspection capabilities and enforcement at retail pharmacy locations. This expansion aims to ensure that the sale of prescription-only medications follows strict legal guidelines.
To further safeguard public health, the Ministry is actively engaged in educational initiatives aimed at raising awareness about the dangers tied to the misuse of prescription medications without proper medical oversight.
This comprehensive approach reflects a commitment to not only enforce regulations but also to educate the public on responsible medication use, highlighting the Ministry's proactive stance in safeguarding health across the nation.
